← Back to Journals

Signal Transduction and Targeted Therapy

Publisher:
Springer Nature
ISSN:
2095-9907
Category:
CELL BIOLOGY
Impact factor:
40.8

Feed status

37 parsed articles

Last update: Not fetched

Latest articles

Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial

2026-06-16

Yi Pan

Signal Transduction and Targeted Therapy, Published online: 16 June 2026; doi:10.1038/s41392-026-02779-1 Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial]]>

DOI: 10.1038/s41392-026-02779-1